Frank E. Thomas
2014
In 2014, Frank E. Thomas earned a total compensation of $1.6M as President and Chief Operating Officer at AMAG Pharmaceuticals, a 32% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $321,300 |
|---|---|
| Option Awards | $302,206 |
| Salary | $435,831 |
| Stock Awards | $487,078 |
| Other | $7,800 |
| Total | $1,554,215 |
Thomas received $487.1K in stock awards, accounting for 31% of the total pay in 2014.
Thomas also received $321.3K in non-equity incentive plan, $302.2K in option awards, $435.8K in salary and $7.8K in other compensation.
Rankings
In 2014, Frank E. Thomas' compensation ranked 5,590th out of 13,032 executives tracked by ExecPay. In other words, Thomas earned more than 57.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,590 out of 13,032 | 57th |
Division Manufacturing | 2,000 out of 4,965 | 60th |
Major group Chemicals And Allied Products | 679 out of 1,690 | 60th |
Industry group Drugs | 527 out of 1,369 | 62nd |
Industry Pharmaceutical Preparations | 409 out of 1,042 | 61st |
Source: SEC filing on April 20, 2017.
Thomas' colleagues
We found four more compensation records of executives who worked with Frank E. Thomas at AMAG Pharmaceuticals in 2014.